title: Could no benefit of cyclophosphamide treatment be due to decreased fibrinolytic activity in adults with severe Henoch Schönlein nephritis?
authors: Jae Il
authors: JI
authors: Shin
authors: Se Jin
authors: SJ
authors: Park
authors: Ji Hong
authors: JH
authors: Kim
mesh_terms: D000328:Adult; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D011695:IgA Vasculitis / Q000097:blood / Q000188:drug therapy*; D009393:Nephritis / Q000097:blood / Q000188:drug therapy*; D013256:Steroids / Q000008:administration & dosage; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
chemical_list: D005343:Fibrinolytic Agents; D013256:Steroids; D003520:Cyclophosphamide; D014568:Urokinase-Type Plasminogen Activator